ArticleFrontiers in oncology2026
Irreversible blindness from hydrocephalus in recurrent pediatric pilocytic astrocytoma: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pilocytic astrocytoma (PA) is the most common pediatric brain tumor, typically associated with favorable outcomes following surgical resection. However, irreversible vision loss due to elevated intracranial pressure (ICP) in posterior fossa PA is rare and often underrecognized. This case highlights the consequences of delayed detection of tumor recurrence and the critical importance of long-term surveillance in pediatric brain tumor survivors. Case Presentation: A 14-year-old male with a history of posterior fossa PA resection at age 4 presented with progressive headache, vomiting, and rapidly deteriorating vision after being lost to follow-up for 10 years. Neuroimaging revealed tumor recurrence with obstructive hydrocephalus. Imaging confirmed that the recurrent tumor was confined to the posterior fossa with no extension to or compression of the optic nerves, chiasm, or tracts. Despite emergency cerebrospinal fluid diversion and subtotal tumor resection followed by CyberKnife radiotherapy (45 Gy in 25 fractions), the patient developed permanent bilateral blindness. Fundoscopy confirmed severe bilateral optic disc atrophy most likely secondary to prolonged elevated ICP rather than direct tumor compression, although alternative contributing mechanisms could not be entirely excluded given the complex clinical course. At six-month follow-up, the patient remained clinically stable with no tumor progression but persistent vision loss and residual cerebellar dysfunction. Conclusion: This case demonstrates that posterior fossa PA recurrence can lead to irreversible blindness, most likely through sustained elevated ICP, even in the absence of direct optic pathway involvement. It underscores the necessity of systematic long-term surveillance protocols and prompt hydrocephalus management in pediatric brain tumor patients to prevent devastating but potentially avoidable complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.